期刊文献+

20例经典型泛酸激酶相关神经变性的临床表型和基因型特点

Phenotypic and genotypic features of twenty children with classic pantothenate kinase-associated neurodegeneration
原文传递
导出
摘要 目的 分析经典型泛酸激酶相关神经变性患儿的临床和基因特点.方法 回顾性总结北京大学第一医院2006年11月至2016年12月确诊为泛酸激酶相关神经变性的患儿资料,分析其临床表现、影像学特点和基因检查结果.结果 共20例确诊为泛酸激酶相关神经变性的患儿纳入研究,均为经典型,起病年龄的中位数为3.5(1.0 ~ 10.0)岁,首发症状主要为下肢肌张力不全(16例),末次随访所有患儿均出现肢体肌张力不全,部分逐渐出现吞咽障碍(11例)、言语障碍(16例)、锥体束受累(7例)、智力倒退(3例)、视网膜色素变性(5例),起病至失去行走能力的中位数年龄为6.9(2.0 ~12.0)年.19例患儿头颅磁共振成像(MRI)存在“虎眼征”,4例患儿CT发现苍白球区钙化.共发现26种基因突变,其中16种为新发突变.c.1502T>C(p.Ile501 Asn)突变最多见(4例).结论 经典型泛酸激酶相关神经变性患儿以肌张力不全为主要临床表现,进展至失去行走能力时间短.除头颅MRI有“虎眼征”表现外,头颅CT苍白球区钙化可能为泛酸激酶相关神经变性的另一影像学特征.本组发现16种PANK2基因新突变. Objective To explore the phenotypic and genotypic characteristics in Chinese children with classic pantothenate kinase-associated neurodegeneration (PKAN).Method The clinical,radiographic and genetic data of all PKAN patients diagnosed at pediatric department of Peking University First Hospital from November 2006 to December 2016 were retrospectively collected and analyzed.Result Twenty patients with classic PKAN were included in the study.The median age at onset was 3.5 years (ranging from 1.0 to 10.0 years),and the most common initial symptom was gait disturbance (16 cases).At the last evaluation,the clinical features were limbs dystonia (20 cases),dysarthria (16 cases),dysphagia (11 cases),pyramidal sign (7 cases),mental regression (3 cases) and pigmentary retinopathy (5 cases).For those classic PKAN patients,the median time from onset of disease to loss of independent ambulation was 6.9 years (ranging from 2.0 to 12.0 years).Imaging data showed,except "eye of tiger" in MRI (19 cases),globus pallidus calcification in CT was also found in four patients.In gene testing,26 different mutations in PANK2 gene were identified,and 16 of 26 were novel mutations.Moreover,c.1502T 〉 C (p.Ile501Asn) was the most common mutation (4 cases).Conclusion Dystonia is the major neurologic feature of classic PKAN.Disease progression is rapid,with loss of independent ambulation within 10 years after onset.Except "eye of tiger" in MRI,globus pallidus calcification in CT may be another imaging feature of PKAN.Sixteen novel mutations of PANK2 gene were identified in the study.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2017年第9期678-682,共5页 Chinese Journal of Pediatrics
基金 儿科遗传性疾病分子诊断与研究北京市重点实验室资助(BZ0317)
关键词 泛酸激酶相关性神经退行性疾病 基因型 基因 PANK2 Pantothenate kinase-associated neurodegeneration Genotype Genes,PANK2
  • 相关文献

参考文献3

二级参考文献79

  • 1Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.Nat Genet,2001,28:345- 349.
  • 2Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med,2003,348 : 33 -40.
  • 3Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol, 1974,30:70-83.
  • 4Swainman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol, 1991,48 : 1285-1293.
  • 5Swainman KF. Hallervorden-Spatz syndrome. Pediatr Neurol,2001,25 : 102-108.
  • 6Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation ( Hallervorden-Spatz syndrome ) and pankothenate kinase-associated neurodegeneration. Mov Disord ,2004,19:36-42.
  • 7Johnson MA, Kuo YM, Westaway SK, et al. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.Ann N Y Acad Sci,2004,1012:282-298.
  • 8Yoon SJ, Koh YH, Floyd RA, et al. Copper, zinc superoxide dismutase enhances DNA damage and mutagenicity induced by cysteine/iron. Mutat Res,2000, 448:97-104.
  • 9Tabrizi S. Neurodegenerative diseases neurobiology patho?genesis and therapeutics. J Neurol Neurosurg Psychiatry 2006; 77(2): 284.
  • 10Berg D, Hochstrasser H, Schweitzer KJ, Riess O. Distur?bance of iron metabolism in Parkinson's disease - ultra?sonography as a biomarker. Neurotox Res 2006; 9(1): 1-13.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部